For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Buscar Close Search
Page Menu

image0l1lc.png

We have uncovered, and continue to catalogue, the "endotoxome": metabolites and metabolic
intermediates normally produced during metabolism, that in excess have highly toxic properties.
By exploiting the differences in metabolic activities between cancer and normal cells, we can strategically and selectively overload cancer cells with their own toxic metabolites as a therapeutic approach (publications). Additionally, we explore the notion that these toxic metabolites are playing hitherto unrecognized roles in diseases outside of cancer, such as in aging and neurodegenerative disorders.

We are also part of the:

imagewustn.png

imagefeeab.png

<The Kim lab is currently hiring motivated Postdocs, Grad Students, and Technicians!>

blobid8.png

Our home: UMass Medical School